Allarity Therapeutics Inc (NASDAQ: ALLR)’s stock price has gone decline by -5.80 in comparison to its previous close of 1.12, however, the company has experienced a -26.74% decrease in its stock price over the last five trading days. accessnewswire.com reported 2025-02-04 that NEW YORK, NY / ACCESS Newswire / February 4, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Allarity Therapeutics, Inc. (“Allarity” or “the Company”) (NASDAQ:ALLR). Investors who purchased Allarity securities prior to May 17, 2022, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/ALLR.
Is It Worth Investing in Allarity Therapeutics Inc (NASDAQ: ALLR) Right Now?
Additionally, the 36-month beta value for ALLR is 0.20. There are mixed opinions on the stock, with 0 analysts rating it as a “buy,” 0 rating it as “overweight,” 1 rating it as “hold,” and 0 rating it as “sell.”
The public float for ALLR is 3.39M and currently, short sellers hold a 16.14% ratio of that float. The average trading volume of ALLR on February 05, 2025 was 1.59M shares.
ALLR’s Market Performance
ALLR’s stock has seen a -26.74% decrease for the week, with a -4.95% drop in the past month and a -24.64% fall in the past quarter. The volatility ratio for the week is 18.34%, and the volatility levels for the past 30 days are at 19.90% for Allarity Therapeutics Inc The simple moving average for the past 20 days is -7.84% for ALLR’s stock, with a -86.23% simple moving average for the past 200 days.
ALLR Trading at -5.30% from the 50-Day Moving Average
After a stumble in the market that brought ALLR to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -99.63% of loss for the given period.
Volatility was left at 19.90%, however, over the last 30 days, the volatility rate increased by 18.34%, as shares sank -0.94% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -16.00% lower at present.
During the last 5 trading sessions, ALLR fell by -27.08%, which changed the moving average for the period of 200-days by -97.67% in comparison to the 20-day moving average, which settled at $1.1445. In addition, Allarity Therapeutics Inc saw -9.83% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for ALLR
Current profitability levels for the company are sitting at:
- -221.46 for the present operating margin
- 0.89 for the gross margin
The net margin for Allarity Therapeutics Inc stands at -172.73. The total capital return value is set at -1.91. Equity return is now at value -391.95, with -109.68 for asset returns.
Based on Allarity Therapeutics Inc (ALLR), the company’s capital structure generated 0.09 points at debt to capital in total, while cash flow to debt ratio is standing at -11.83. The debt to equity ratio resting at 0.1. The interest coverage ratio of the stock is -30.7.
Currently, EBITDA for the company is -12.08 million with net debt to EBITDA at 0.92. When we switch over and look at the enterprise to sales, we see a ratio of -111.15. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.75.
Conclusion
In conclusion, Allarity Therapeutics Inc (ALLR) has seen bad performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
